J Knee Surg 2021; 34(03): 298-302
DOI: 10.1055/s-0039-1695716
Original Article

Cost Analysis of Medicare Patients with Varying Complexities Who Underwent Total Knee Arthroplasty

Hiba K. Anis
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Nipun Sodhi
2   Department of Orthopaedic Surgery, Lenox Hill Hospital, Northwell Health, New York
,
Rushabh M. Vakharia
3   Department of Orthopaedic Surgery, Holy Cross Hospital, Fort Lauderdale, Florida
,
Giles R. Scuderi
2   Department of Orthopaedic Surgery, Lenox Hill Hospital, Northwell Health, New York
,
4   Department of Orthopaedic Surgery, University of Louisville, Louisville, Kentucky
,
Martin W. Roche
3   Department of Orthopaedic Surgery, Holy Cross Hospital, Fort Lauderdale, Florida
,
Michael A. Mont
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
2   Department of Orthopaedic Surgery, Lenox Hill Hospital, Northwell Health, New York
› Author Affiliations

Abstract

The effort to reduce overall healthcare costs may affect more complex patients, as their pre- and postoperative care can be substantially involved. Therefore, the purpose of this study was to use a large nationwide insurance database to compare (1) costs, (2) reimbursements, and (3) net losses of 90-day episodes of care (EOC) for total knee arthroplasty (TKA) patients according to Elixhauser's Comorbidity Index (ECI) scores. All TKAs performed between 2005 and 2014 in the Medicare Standard Analytic Files were extracted from the database and stratified based on ECI scores, ranging from 1 to 5. ECI 1 patients served as the control cohort, while ECI 2, 3, 4, and 5 patients were considered study cohorts. Each study cohort and control cohort were matched based on age and sex, resulting in a total of 715,398 patients included for analysis. Total EOC costs, reimbursements, and total net losses (defined as total EOC costs minus total EOC reimbursements) were compared between the cohorts. Overall, total EOC costs increased with ECI. For example, compared with the matched ECI 1 cohorts, the total EOC costs for ECI 5 patients ($56,589.19 vs. $51,747.54) were significantly greater (p < 0.01). Although reimbursements increased with increasing ECI, so did net losses. The net losses for ECI 5 patients were greater than that for ECI 1 patients ($42,309.39 vs. $40,007.82). The bundled payments for care improvement (BPCI) and comprehensive care for joint replacement (CJR) are alternative payment models that might de-incentivize treatment of more complex patients. Our study found that despite increasing reimbursements, overall costs, and therefore net losses, were greater for more complex patients with higher ECI scores.



Publication History

Received: 17 April 2019

Accepted: 15 July 2019

Article published online:
28 August 2019

© 2019. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Peterson J, Sodhi N, Khlopas A. et al. A comparison of relative value units in primary versus revision total knee arthroplasty. J Arthroplasty 2018; 33 (7S): S39-S42
  • 2 Sodhi N, Piuzzi NS, Khlopas A. et al. Are we appropriately compensated by relative value units for primary vs revision total hip arthroplasty?. J Arthroplasty 2018; 33 (02) 340-344
  • 3 Orr RD, Sodhi N, Dalton SE. et al. What provides a better value for your time? The use of relative value units to compare posterior segmental instrumentation of vertebral segments. Spine J 2018; 18 (10) 1727-1732
  • 4 Kamath AF, Courtney PM, Bozic KJ, Mehta S, Parsley BS, Froimson MI. Bundled payment in total joint care: survey of AAHKS membership attitudes and experience with alternative payment models. J Arthroplasty 2015; 30 (12) 2045-2056
  • 5 Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998; 36 (01) 8-27
  • 6 Dominick KL, Dudley TK, Coffman CJ, Bosworth HB. Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Rheum 2005; 53 (05) 666-672
  • 7 Xiao H, Tan F, Goovaerts P. et al. Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data. J Registry Manag 2013; 40 (04) 159-164
  • 8 Lieffers JR, Baracos VE, Winget M, Fassbender K. A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer 2011; 117 (09) 1957-1965
  • 9 Menendez ME, Neuhaus V, van Dijk CN, Ring D. The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopaedic surgery. Clin Orthop Relat Res 2014; 472 (09) 2878-2886
  • 10 Centers for Medicare & Medicaid Services. Medicare Fee-for-Service 2012 Improper Payments Report. Accessed July 25, 2019 at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Monitoring-Programs/CERT/Downloads/MedicareFeeforService2012ImproperPaymentsReport.pdf
  • 11 Cram P, Ravi B, Vaughan-Sarrazin MS, Lu X, Li Y, Hawker G. What drives variation in episode-of-care payments for primary TKA? An Analysis of Medicare Administrative Data. Clin Orthop Relat Res 2015; 473 (11) 3337-3347
  • 12 Li Y, Lu X, Wolf BR, Callaghan JJ, Cram P. Variation of Medicare payments for total knee arthroplasty. J Arthroplasty 2013; 28 (09) 1513-1520
  • 13 Knoedler MA, Jeffery MM, Philpot LM. et al. Risk factors associated with health care utilization and costs of patients undergoing lower extremity joint replacement. Mayo Clin Proc Innov Qual Outcomes 2018; 2 (03) 248-256
  • 14 Plate JF, Brown ML, Wohler AD, Seyler TM, Lang JE. Patient factors and cost associated with 90-day readmission following total hip arthroplasty. J Arthroplasty 2016; 31 (01) 49-52
  • 15 Maradit Kremers H, Visscher SL, Moriarty JP. et al. Determinants of direct medical costs in primary and revision total knee arthroplasty. Clin Orthop Relat Res 2013; 471 (01) 206-214
  • 16 Gonzalez Della Valle A, Chiu YL, Ma Y, Mazumdar M, Memtsoudis SG. The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States. J Arthroplasty 2012; 27 (10) 1743-1749.e1
  • 17 Cram P, Lu X, Li Y. Bundled payments for elective primary total knee arthroplasty: an analysis of medicare administrative data. Geriatr Orthop Surg Rehabil 2015; 6 (01) 3-10
  • 18 Memtsoudis SG, Stundner O, Rasul R. et al. The impact of sleep apnea on postoperative utilization of resources and adverse outcomes. Anesth Analg 2014; 118 (02) 407-418
  • 19 Courtney PM, Ashley BS, Hume EL, Kamath AF. Are bundled payments a viable reimbursement model for revision total joint arthroplasty?. Clin Orthop Relat Res 2016; 474 (12) 2714-2721